Immunome Inc. (IMNM) has 16 SEC Form 4 insider filings on record in the last 90 days. No insider purchases were filed — 5 sales totalling $10.3M. Most recent filing: Sept. 15, 2026.
| Date | Insider | Value | Shares | Stake | Pre-planned | Links |
|---|---|---|---|---|---|---|
| Sept. 15, 2026 filed Sept. 11, 2026 | Higgins Jack Chief Scientific Officer | −$60,768 | 58,000 | −3% | Yes | |
|
|
||||||
| Aug. 12, 2026 filed Aug. 10, 2026 | Barchas Isaac Director | −$2,198,910 | 83,464 | −48% | Yes | |
|
|
||||||
| Aug. 10, 2026 filed Aug. 6, 2026 | Barchas Isaac Director | −$940,453 | 36,088 | −33% | Yes | |
|
|
||||||
| Aug. 6, 2026 filed Aug. 4, 2026 | Horn Kinney CHIEF BUSINESS OFFICER | $1,102,797 | 271,848 | 0% | Yes | |
|
|
||||||
| July 27, 2026 filed July 23, 2026 | Tsai Philip Chief Technical Officer | $0 | 114,750 | +100% | No | |
|
|
||||||
Showing the 5 most recent of 16 filings in the last 90 days.
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.
Real-time Telegram alerts the moment a Form 4 is filed. Filings shown here are delayed by 72 hours.
Start free